–
Atossa Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.5
FY22:
−27.7
FY23:
−31.4
FY24:
−27.6
FY25:
−37.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.5
FY22:
−27.7
FY23:
–
FY24:
−25.9
FY25:
−37.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.6
FY22:
−27.0
FY23:
−30.1
FY24:
−25.5
FY25:
−34.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.6
FY22:
−27.0
FY23:
−30.1
FY24:
−25.5
FY25:
−34.8
All amounts in millions USD